Automera
5 known investors
Find your way into Automera
342 people in our graph share verified history with the Automera team — schools, employers, funds. One of them is your warm intro.
Adam Valkinunlockedknows Thong Q. Le · together at Harvard University (overlapped)
×10knows the team · via Harvard University
knows the team · via Deep Genomics
Automera develops an autophagy-powered small molecule degrader platform designed to accelerate drug development and reduce costs in therapeutic creation. The company targets pharmaceutical and biotech organizations seeking novel technologies for small molecule drug discovery.
Founders & leadership
ZW
Zian-Loong WangChief Technology Officer & Co-Founder
ML
Michael LazarouinCo-Founder
TQ
Thong Q. LeinChief Executive OfficerThong Q. Le is Chief Executive Officer of Automera, which develops an autophagy-powered small molecule degrader platform for drug discovery. He brings over 25 years of life sciences investment experience, including roles as Senior Managing Director and Chairman of Accelerator Life Science Partners (a venture capital firm he joined in 2013) and Managing Director at WRF Capital, where he supported early-stage life sciences companies; he holds an A.B. in Government from Harvard University and postgraduate business studies from Templeton College, Oxford University.
Investors · 5
ACCELERATOR LIFE SCIENCE PARTNERS✓ verifiedSeattle
ClavystBioSingapore
Xora Innovation Pte Ltdreported · 2 sourcesSingapore
Also in the syndicate · 2
ALSPleadEDBI
Funding
SEC filings, press & company announcements$16M disclosed across 1 of 2 rounds · 2023
- $16MSeries ASep 2023 · 5 sources
Accelerator Life Science Partners (ALSP) (lead), ALSP (lead), ClavystBio (lead), EDBI, Xora Innovation
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Automera do?
- Automera develops an autophagy-powered small molecule degrader platform designed to accelerate drug development and reduce costs in therapeutic creation. The company targets pharmaceutical and biotech organizations seeking novel technologies for small molecule drug discovery.
- Who founded Automera?
- Automera was founded by Zian-Loong Wang, Michael Lazarou.
- Who are Automera's investors?
- Automera's investors include ACCELERATOR LIFE SCIENCE PARTNERS, ClavystBio, Xora Innovation Pte Ltd.
- How much funding has Automera raised?
- Automera has disclosed $16M raised across 1 of its 2 known rounds.